AUSTIN, Texas, Jan. 5, 2021 /PRNewswire/ — Santé Ventures (Santé), an early-stage healthcare and life sciences investment firm, today announced a series of end-of-year senior appointments and promotions, including naming two new Partners, to strengthen the firm’s senior leadership team across venture investing, capital formation, and data & analytics. James Eadie, MD, a current […]
Other News
CorWave Raises $40 Million in Series C Funding for Its Breakthrough Heart Pump
CLICHY, France–(BUSINESS WIRE)–CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology: the wave membrane pump. These new funds will enable CorWave to finalize development of its initial product, expand a […]
Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease
EchoGo Pro is an AI service for automated identification of coronary artery disease – FDA gives 510(K) clearance for EchoGo Pro, expanding the use of Ultromics’ EchoGo service to support clinicians diagnosing coronary artery disease – Every year in the U.S. over 800,000 people die from heart disease – accounting […]
Zynex Announces a Second Utility Patent for Its Blood Volume Monitor
ENGLEWOOD, Colo., Jan. 6, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has obtained a second U.S. Utility patent for its Blood Volume Monitor Device. Thomas Sandgaard, the […]
Biome Analytics Supports Research Aimed at Saving Lives and Improving Outcomes in Cardiovascular Procedure
Research featured in JAHA article: Refining Safe Contrast Limits for Preventing Acute Kidney Injury After Percutaneous Coronary Intervention SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company, announces the results of original research published in the Journal of the American Heart Association (JAHA). Cardiovascular disease remains the leading cause of […]
ZOLL Medical’s Advanced Defibrillators Win Five-Star World of Safety & Health Asia Award 2020
ZOLL AED 3 and ZOLL AED 3 BLS Recognized by World of Safety & Health Asia for Their Innovative Technology for All Rescuers CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that its ZOLL AED 3® and ZOLL AED 3 BLS automated […]
BioVentrix Announces Jerry Estep, MD, as Co-Principal Investigator for ALIVE Pivotal Trial Studying Transcatheter Device for Heart Failure
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter Ventricular Restoration (TCVR), today announced that heart failure specialist Jerry Estep, MD, of the Cleveland Clinic has been appointed co-principal investigator of the pivotal ALIVE Trial studying LIVE™ Therapy using the Revivent TC™ […]
Percutaneous Coronary Sinus–Based Mitral Valve Annuloplasty in Atrial Functional Mitral Regurgitation
Atrial functional mitral regurgitation (aFMR) is associated with left atrial (LA) and mitral annular dilatation most often caused by atrial fibrillation or heart failure with preserved ejection fraction (HFpEF). (A) Echocardiographic assessment, (B) functional mitral regurgitation classification, (C) New York Heart Association classification, and (D) mitral annulus diameter at baseline, […]
VOLTA MEDICAL raises 28 million USD to revolutionize persistent AFib ablation
MARSEILLE, France, Jan. 5, 2021 /PRNewswire/ — Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 28 million USD. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will […]
Impulse Dynamics Announces First Heart Failure Patient Treated With CCM Therapy in Brazil
Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the first patient in Brazil was treated with its innovative CCM® therapy delivered by the Optimizer® system. The patient was treated […]



